Ignite Creation Date:
2024-05-06 @ 12:24 AM
Last Modification Date:
2024-10-26 @ 10:49 AM
Study NCT ID:
NCT01562028
Status:
COMPLETED
Last Update Posted:
2022-08-24
First Post:
2012-03-22
Brief Title:
BELIEF Bevacizumab and ErLotinib In EGFR Mut NSCLC
Sponsor:
Organization:
ETOP IBCSG Partners Foundation